Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
Pancreas development in pigs resembles humans much more closely than does the established mouse model. An international team ...
Heifers have unique requirements and challenges leading to individual groups, adjustments in feed additives and rations designed to meet growth and milk needs.
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes ...
Solar companies have figured out how to mix sheep grazing and power production. This company is about to make a push to do it ...
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...
In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
A leading researcher has stressed that double muscling should not be viewed as a flaw, and predicted that more breeds will ...
These long-term findings in a large patient cohort show the sustained clinical efficacy and safety of autologous CD34+ hematopoietic stem-cell lentiviral gene therapy for ADA-SCID, indicating that it ...
The wallet in George Engelmayr’s hand looks unremarkable: tan, textured, a little stiff at the edges. The story behind it is anything but. It was grown in a North Carolina lab from the skin cells of a ...
In a video shared on the social media platform X on Thursday, the investor shared his thoughts on the probe into Tesla. "I don't think that they're [NHTSA] going after Tesla per se," the investor said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results